文献速递艾滋病与性传播感染

围产期感染HIV的青少年和年轻成人对BNT162b2 mRNA新冠疫苗表现出独特的免疫原性

Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.
PubMed 文献 · Clin Infect Dis · 2022-01-01

在28例接受抗逆转录病毒治疗的围产期HIV感染者与65名无新冠感染史的健康对照中评估BNT162b2疫苗的安全性和免疫原性。HIV感染者在第28天抗三聚体S抗体滴度较低(P=0.01),CD4+ T细胞扩增能力受损,但6个月随访时两组抗体滴度维持相似。

要点

  • HIV感染者接种BNT162b2后第28天抗三聚体S抗体滴度低于健康对照(P=0.01)。
  • 仅HIV感染者外周血单核细胞在第28天显示特异性CD40L+ CD4+ T细胞扩增能力受损。
  • 6个月随访时两组间抗体滴度维持相似。

核心结论

  • 接受抗逆转录病毒治疗的HIV感染者对BNT162b2疫苗的应答与健康对照相比具有独特特征,尤其在蛋白质组层面,支持其与健康对照方案类似地有资格接种额外剂量。

研究设计与样本

  • 在28例接受抗逆转录病毒治疗的围产期HIV感染者和65名无新冠感染史的健康对照中评估BNT162b2 mRNA新冠疫苗的安全性和免疫原性。
  • 在基线(第0天)、第二剂时(第21天)及第0天后4周(第28天)和6个月(第180天)采集样本,测量SARS-CoV-2特异性体液和CD4+ T细胞应答。
  • 采用多重邻位延伸分析(Olink)评估第0天和第28天血浆样本的蛋白质组图谱。

主要发现

  • 所有HIV感染者均产生了与健康对照相似的抗SARS-CoV-2体液应答,但第28天抗三聚体S抗体滴度较低(P=0.01)。
  • 仅HIV感染者外周血单核细胞在第28天显示特异性CD40L+ CD4+ T细胞群体扩增能力受损。
  • 6个月随访时两组间维持相似的抗体滴度。
  • 基线蛋白水平与体液或细胞应答相关,鉴定出参与免疫应答调节的分子簇在两组间呈相反模式。

临床怎么用

  • 原文结论认为接受抗逆转录病毒治疗的HIV感染者有资格接种额外剂量,与健康对照方案类似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunization of vulnerable populations with distinct immunity often results in suboptimal immunogenicity, durability, and efficacy. METHODS: Safety and immunogenicity profiles of BNT162b2 messenger RNA coronavirus disease 2019 (COVID-19) vaccine, among people living with human immunodeficiency virus (HIV), were evaluated in 28 perinatally HIV-infected patients under antiretroviral therapy (ART) and 65 healthy controls (HCs) with no previous history of COVID-19. Thus, we measured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific humoral and CD4+ T cell responses. Samples were collected before vaccination (baseline, day [D] 0), at the second dose (D21), and at 4 weeks (D28) and 6 months (D180) after D0. Proteomic profiles at D0 and D28 were assessed with a multiplexed proximity extension assay (Olink) on plasma samples. RESULTS: All HIV-infected patients mounted similar anti-SARS-CoV-2 humoral responses to those of HCs, albeit with lower titers of anti-trimeric S at D28 (P = .01). Only peripheral blood mononuclear cells of HIV-infected patients demonstrated at D28 an impaired ability to expand their specific (CD40L+) CD4+ T-cell populations. Similar humoral titers were maintained between the 2 groups at 6-months follow-up. We additionally correlated baseline protein levels to either humoral or cellular responses, identifying clusters of molecules involved in immune response regulation with inverse profiles between the 2 study groups. CONCLUSIONS: Responses of ART-treated HIV-infected patients, compared to those of HCs, were characterized by distinct features especially within the proteomic compartment, supporting their eligibility to an additional dose, similarly to the HC schedule.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Morrocchi E, Pighi C, Pascucci GR, et al. Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity. Clin Infect Dis. 2022. PMID: 35738253. doi:10.1093/cid/ciac408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。